Clinical Resources

ACOG Practice Bulletin #186 (2017): Long-Acting Reversible Contraception - Implants and Intrauterine Devices

This Practice Bulletin provides recommendations for the use of IUDs and contraceptive implants, the most effective reversible contraceptives. The document provides information for appropriate candidate selection and the management of clinical issues and complications associated with LARC methods.

ACOG Committee Opinion #735 (2018): Adolescents and Long-Acting Reversible Contraception - Implants and Intrauterine Devices

This Committee Opinion recommends the use of IUDs and the contraceptive implant as safe, highly effective contraceptive options for sexually active adolescents desiring to avoid pregnancy.

ACOG Committee Opinion #710 (2017): Counseling Adolescents About Contraception

This Committee Opinion encourages effective counseling regarding contraceptive options and the provision of resources to increase access as key components of adolescent health care. Counseling should include continual reassessment of sexual concerns, behavior, relationships, prevention strategies, and testing for sexually transmitted infections.

ACOG Committee Opinion #707 (2017): Access to Emergency Contraception 

This Committee Opinion examines the barriers to use of emergency contraceptive methods and highlights the importance of increasing access to these methods. Age restrictions, cost, insurance coverage, and misconceptions about EC are all unnecessary barriers that continue to keep women from using this safe and effective method to prevent unwanted pregnancies in the first few days after unprotected sex, sexual assault, or contraceptive failure.

ACOG Committee Opinion #699 (2017): Adolescent Pregnancy, Contraception, and Sexual Activity

This Committee Opinion examines teen pregnancy rates in the U.S. among adolescents, and details ACOG's support of adolescent access to all FDA-approved contraceptive methods. Patient choice, in the absence of contraindications, should be the principal factor in prescribing one method of contraception over another, and dual method use - the use of condoms in combination with more effective contraceptive methods - is advised as the ideal contraceptive practice for adolescents.

ACOG Committee Opinion #672 (2016): Clinical Challenges of Long-Acting Reversible Contraceptive Methods

This Committee Opinion provides recommendations to aid in the diagnosis and treatment of the most common challenges encountered with LARC, such as difficult IUD insertion, nonpalpable implants, nonvisualized strings, and pelvic inflammatory disease (PID). 

ACOG Committee Opinion #670 (2016): Immediate Postpartum Long-Acting Reversible Contraception

This Committee Opinion encourages prenatal counseling of the most effective options for postpartum contraception: IUDs and the implant. Providers should counsel women about the convenience and effectiveness of immediate postpartum LARC, as well as the benefits of reducing unintended pregnancy and lengthening interpregnancy intervals. 

ACOG Committee Opinion #642 (2015): Increasing Access to Contraceptive Implants and Intrauterine Devices To Reduce Unintended Pregnancy

This Committee Opinion encourages the consideration of implants and IUDs for all appropriate candidates, including nulliparous women and adolescents, and recommends strategies to reduce barriers and increase access to LARC as part of the entire family of contraceptive methods.

ACOG Committee Opinion #615 (Reaffirmed 2017): Access to Contraception

This Committee Opinion states that all women should have unhindered and affordable access to all U.S. Food and Drug Administration-approved contraceptives, reviews barriers to contraceptive access, and offers strategies to improve access.


Other Resources

CDC: U.S. Selected Practice Recommendations for Contraceptive Use, 2016

The CDC released this resource offering guidance to health care providers in managing common issues around the initiation and use of specific contraceptive methods. The U.S. Selected Practice Recommendations, 2016 (2016 U.S. SPR) was produced as a companion piece to the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (2016 U.S. MEC). While the U.S. Medical Eligibility Criteria addresses who can use various contraceptive methods, the U.S. Selected Practice Recommendations offers method-specific guidance on common clinical issues, such as what clinical information is needed before method initiation and how to manage side effects. 

CDC: Contraception App for Android and iOS Based on the 2016 U.S. MEC and U.S. SPR

The CDC has developed apps for Android (Google Play Store) and iOS (Apple App Store) based on the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (2016 U.S. MEC) and the U.S. Selected Practice Recommendations for Contraceptive Use, 2016 (2016 U.S. SPR), which give providers an interactive way to access more than 1,800 recommendations for the safety of contraceptive methods among women and men with certain characteristics or medical conditions.  You can also download or order updated guidance documents, provider tools, and other electronic resources as they become available on the CDC Contraceptive Guidance for Health Care Providers website.

CDC: Contraceptive Method Guidance Slide Sets for Health Care Providers

The CDC has developed three slide sets intended to educate health care providers about the U.S. Medical Eligibility Criteria, U.S. Selected Practice Recommendations, and Teen Pregnancy Prevention. The presentations are available as PPT or PDF files, or as a recorded video presentation. Following successful completion of the presentation posttest, participants may be able to receive continuing education credit for their participation.

Journal of Adolescent Health: April 2013 Supplement on Long Acting Reversible Contraceptives for Adolescents and Young Adults

This supplement features a broad range of current research on LARC, covering topics such as effective contraceptive counseling strategiesmyths about LARCpelvic inflammatory disease and IUD usecost as a barrier to LARC use in adolescents, and the effect of LARC on rapid repeat pregnancy in adolescents.

Contact:

Mica Bumpus
LARC Program Director
mbumpus@acog.org

For media inquiries about LARC, please contact:
communications@acog.org
202.863.3321

Advertisement

American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998